ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor - PubMed (original) (raw)
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor
S P Soltoff et al. Mol Cell Biol. 1994 Jun.
Abstract
Conflicting results concerning the ability of the epidermal growth factor (EGF) receptor to associate with and/or activate phosphatidylinositol (PtdIns) 3-kinase have been published. Despite the ability of EGF to stimulate the production of PtdIns 3-kinase products and to cause the appearance of PtdIns 3-kinase activity in antiphosphotyrosine immunoprecipitates in several cell lines, we did not detect EGF-stimulated PtdIns 3-kinase activity in anti-EGF receptor immunoprecipitates. This result is consistent with the lack of a phosphorylated Tyr-X-X-Met motif, the p85 Src homology 2 (SH2) domain recognition sequence, in this receptor sequence. The EGF receptor homolog, ErbB2 protein, also lacks this motif. However, the ErbB3 protein has seven repeats of the Tyr-X-X-Met motif in the carboxy-terminal unique domain. Here we show that in A431 cells, which express both the EGF receptor and ErbB3, PtdIns 3-kinase coprecipitates with the ErbB3 protein (p180erbB3) in response to EGF. p180erbB3 is also shown to be tyrosine phosphorylated in response to EGF. In contrast, a different mechanism for the activation of PtdIns 3-kinase in response to EGF occurs in certain cells (PC12 and A549 cells). Thus, we show for the first time that ErbB3 can mediate EGF responses in cells expressing both ErbB3 and the EGF receptor.
Similar articles
- Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
Gamett DC, Greene T, Wagreich AR, Kim HH, Koland JG, Cerione RA. Gamett DC, et al. J Biol Chem. 1995 Aug 11;270(32):19022-7. doi: 10.1074/jbc.270.32.19022. J Biol Chem. 1995. PMID: 7642563 - Interaction between the epidermal growth factor receptor and phosphoinositide kinases.
Cochet C, Filhol O, Payrastre B, Hunter T, Gill GN. Cochet C, et al. J Biol Chem. 1991 Jan 5;266(1):637-44. J Biol Chem. 1991. PMID: 1845983 - Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KL 3rd. Guy PM, et al. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8132-6. doi: 10.1073/pnas.91.17.8132. Proc Natl Acad Sci U S A. 1994. PMID: 8058768 Free PMC article. - Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.
Kim HH, Sierke SL, Koland JG. Kim HH, et al. J Biol Chem. 1994 Oct 7;269(40):24747-55. J Biol Chem. 1994. PMID: 7929151
Cited by
- Bilateral regulation of EGFR activity and local PI(4,5)P2 dynamics in mammalian cells observed with superresolution microscopy.
Abe M, Yanagawa M, Hiroshima M, Kobayashi T, Sako Y. Abe M, et al. Elife. 2024 Nov 8;13:e101652. doi: 10.7554/eLife.101652. Elife. 2024. PMID: 39513999 Free PMC article. - Large-scale control over collective cell migration using light-controlled epidermal growth factor receptors.
Suh K, Thornton R, Farahani PE, Cohen D, Toettcher J. Suh K, et al. bioRxiv [Preprint]. 2024 May 31:2024.05.30.596676. doi: 10.1101/2024.05.30.596676. bioRxiv. 2024. PMID: 38853934 Free PMC article. Preprint. - Global signal peptide profiling reveals principles of selective Sec61 inhibition.
Wenzell NA, Tuch BB, McMinn DL, Lyons MJ, Kirk CJ, Taunton J. Wenzell NA, et al. Nat Chem Biol. 2024 Sep;20(9):1154-1163. doi: 10.1038/s41589-024-01592-7. Epub 2024 Mar 22. Nat Chem Biol. 2024. PMID: 38519575 - Busting the Breast Cancer with AstraZeneca's Gefitinib.
Chemmalar S, Intan Shameha AR, Che Abdullah CA, Ab Razak NA, Yusof LM, Ajat M, Chan KW, Abu Bakar Zakaria MZ. Chemmalar S, et al. Adv Pharmacol Pharm Sci. 2023 Dec 4;2023:8127695. doi: 10.1155/2023/8127695. eCollection 2023. Adv Pharmacol Pharm Sci. 2023. PMID: 38090376 Free PMC article. Review. - Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis.
Lim M, Fletcher NL, Saunus JM, McCart Reed AE, Chittoory H, Simpson PT, Thurecht KJ, Lakhani SR. Lim M, et al. Mol Pharm. 2023 Dec 4;20(12):6169-6183. doi: 10.1021/acs.molpharmaceut.3c00558. Epub 2023 Nov 16. Mol Pharm. 2023. PMID: 37970806 Free PMC article.
References
- J Biol Chem. 1987 Feb 5;262(4):1644-51 - PubMed
- J Biol Chem. 1985 Jul 25;260(15):8824-30 - PubMed
- Science. 1987 Sep 18;237(4821):1452-8 - PubMed
- Biochem J. 1987 Oct 1;247(1):165-74 - PubMed
- EMBO J. 1988 Jun;7(6):1647-51 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous